Top 5 Emerging Countries Generics Market Summary, Competitive Analysis and Forecast to 2027


Summary

The Emerging 5 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.


Key Highlights

  • These countries contributed $139,492.2 million to the global generics industry in 2022, with a compound annual growth rate (CAGR) of 12.1% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $210,704.1 million in 2027, with a CAGR of 8.6% over the 2022-27 period.
  • Within the generics industry, China is the leading country among the top 5 emerging nations, with market revenues of $111,666.9 million in 2022. This was followed by India and Mexico with a value of $17,617.5 and $6,036.8 million, respectively.
  • China is expected to lead the generics industry in the top five emerging nations, with a value of $171,144.4 million in 2027, followed by India and Mexico with expected values of $26,308.6 and $7,402.3 million, respectively.




Scope

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five generics market
  • Leading company profiles reveal details of key generics market players’ emerging five operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the emerging five generics market with five year forecasts by both value and volume
  • Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country




Reasons To Buy

  • What was the size of the emerging five generics market by value in 2022?
  • What will be the size of the emerging five generics market in 2027?
  • What factors are affecting the strength of competition in the emerging five generics market?
  • How has the market performed over the last five years?
  • How large is the emerging five generics market in relation to its regional counterparts?